DNA vaccines: an historical perspective and view to the future

MA Liu - Immunological reviews, 2011 - Wiley Online Library
This review provides a detailed look at the attributes and immunologic mechanisms of
plasmid DNA vaccines and their utility as laboratory tools as well as potential human …

Prime-boost vaccine strategy against viral infections: Mechanisms and benefits

K Kardani, A Bolhassani, S Shahbazi - Vaccine, 2016 - Elsevier
The essential goal of vaccination is to generate potent and long-term protection against
diseases. Among different vaccine modalities, prime-boost vaccine strategies could …

[HTML][HTML] A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity

MDJ Dicks, AJ Spencer, NJ Edwards, G Wadell… - PloS one, 2012 - journals.plos.org
Recombinant adenoviruses are among the most promising tools for vaccine antigen
delivery. Recently, the development of new vectors has focused on serotypes to which the …

Heterologous prime–boost vaccination

S Lu - Current opinion in immunology, 2009 - Elsevier
An effective vaccine usually requires more than one time immunization in the form of prime–
boost. Traditionally the same vaccines are given multiple times as homologous boosts. New …

[HTML][HTML] Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

KJ Ewer, GA O'Hara, CJA Duncan, KA Collins… - Nature …, 2013 - nature.com
Induction of antigen-specific CD8+ T cells offers the prospect of immunization against many
infectious diseases, but no subunit vaccine has induced CD8+ T cells that correlate with …

Technologies for enhanced efficacy of DNA vaccines

F Saade, N Petrovsky - Expert review of vaccines, 2012 - Taylor & Francis
Despite many years of research, human DNA vaccines have yet to fulfill their early promise.
Over the past 15 years, multiple generations of DNA vaccines have been developed and …

HLA and infectious diseases

JM Blackwell, SE Jamieson… - Clinical microbiology …, 2009 - Am Soc Microbiol
Following their discovery in the early 1970s, classical human leukocyte antigen (HLA) loci
have been the prototypical candidates for genetic susceptibility to infectious disease …

[HTML][HTML] A review of malaria vaccine clinical projects based on the WHO rainbow table

L Schwartz, GV Brown, B Genton, VS Moorthy - Malaria journal, 2012 - Springer
Abstract Development and Phase 3 testing of the most advanced malaria vaccine, RTS,
S/AS01, indicates that malaria vaccine R&D is moving into a new phase. Field trials of …

Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1

TK Berthoud, M Hamill, PJ Lillie… - Clinical infectious …, 2011 - academic.oup.com
Background. Influenza A viruses cause occasional pandemics and frequent epidemics.
Licensed influenza vaccines that induce high antibody titers to the highly polymorphic viral …

[HTML][HTML] Experimental human challenge infections can accelerate clinical malaria vaccine development

RW Sauerwein, M Roestenberg… - Nature Reviews …, 2011 - nature.com
Malaria is one of the most frequently occurring infectious diseases worldwide, with almost 1
million deaths and an estimated 243 million clinical cases annually. Several candidate …